Adlai Nortye Ltd (ANL) Actualités

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Adlai Nortye Reports Unaudited First Half 2024 Financial Results and Highlights Recent Operational Progress

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd...

Adlai Nortye Appoints Roger Sawhney, M.D. to Its Board of Directors

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd...

Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, May 23, 2024 (GLOBE NEWSWIRE) -- Adlai...

Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, May 22, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd...

Form S-8 - Securities to be offered to employees in employee benefit plans

Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, March 29, 2024 (GLOBE NEWSWIRE) -- Adlai...

Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Adlai...

Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd...

Adlai Nortye Ltd. Announces Closing of Initial Public Offering

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Adlai...

Adlai Nortye Ltd. Announces Pricing of Initial Public Offering

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Adlai...

Further re Dir Change

RNS Number:3373U Abbey National PLC 16 January 2004 BOARD CHANGES AT ABBEY Further to the announcement made on 19 December 2003 at...

FRN Variable Rate Fix

Abbey National PLC As Agent Bank, please be advised of the following rate determined on: 08-Jan-2004 Issue : Abbey National Treasury Services...

Completion of Italy sale

RNS Number:7635T Abbey National PLC 31 December 2003 Abbey National Plc ("Abbey") 31 December 2003 Abbey Announces Completion...

FRN Variable Rate Fix

Abbey National PLC As Agent Bank, please be advised of the following rate determined on: 23-Dec-2003 Issue : Abbey National Plc EUR 500,000,000...